| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848026 | American Journal of Kidney Diseases | 2014 | 8 Pages |
Abstract
Low serum testosterone concentration may be a modifiable risk factor for adverse outcomes and poor quality of life in male hemodialysis patients. This hypothesis should be tested in randomized controlled trials.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Aminu K. MD, PhD, Peter MD, PhD, Meng MSci, Brenda MD, PhD, Ravi MD, MPH, Scott MD, MSci, Christopher MD, Deborah MD, George MD, PhD, Giovanni MD, PhD, Juan-Jesus PhD, Marcello MD, SM,